Margaret Billingham | Academic Influence

Margaret Billingham's AcademicInfluence.com Rankings

Margaret Billingham

Biology

#5008

World Rank

#7386

Historical Rank

Pathology

#58

World Rank

#127

Historical Rank

biology Degrees

Margaret Billingham

Philosophy

#4840

World Rank

#7497

Historical Rank

Logic

#2218

World Rank

#3163

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Margaret Billingham's Degrees

Bachelors Medicine University of Nairobi
PhD Pathology University of Nairobi

Why Is Margaret Billingham Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Margaret E. Billingham was a pathologist at Stanford University Medical Center, who made significant achievements in the early recognition and grading of transplant rejection following cardiac transplantation, known as 'Billingham's Criteria'. She also described chronic rejection and techniques in heart endomyocardial biopsy.

(See a Problem?)

Margaret Billingham's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. (1982) (2373)
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. (1990) (1640)
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. (2005) (1303)
Myocarditis. A histopathologic definition and classification. (1987) (1276)
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. (1995) (1150)
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. (1993) (753)
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. (1992) (716)
Anthracycline cardiomyopathy monitored by morphologic changes. (1978) (587)
Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling (2006) (486)
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. (1978) (386)
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. (1984) (380)
Early anthracycline cardiotoxicity. (1978) (320)
The spectrum of coronary artery pathologic findings in human cardiac allografts. (1989) (303)
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. (1982) (297)
Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients. (1978) (295)
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. (1980) (288)
Histopathology of graft coronary disease. (1992) (277)
Transplant coronary artery disease: histopathologic correlations with angiographic morphology. (1991) (265)
Clinical spectrum of anthracycline antibiotic cardiotoxicity. (1978) (255)
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. (1987) (250)
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. (1990) (249)
Calcific deposits in porcine bioprostheses: structure and pathogenesis. (1980) (242)
Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. (1981) (238)
The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. (1998) (236)
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. (1995) (231)
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. (1983) (230)
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. (1993) (222)
Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. (1984) (220)
Intravascular ultrasound imaging of coronary arteries. Is three layers the norm (1991) (199)
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. (1983) (190)
Pathologic pulmonary alterations in long-term human heart-lung transplantation. (1985) (179)
Detection of Coronary Atherosclerosis in Young Adult Hearts Using Intravascular Ultrasound (1992) (178)
Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. (1974) (174)
Acute and Chronic Cardiovascular Effects of Doxorubicin in the Dog: The Cardiovascular Pharmacology of Drug‐Induced Histamine Release (1980) (173)
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. (1999) (170)
Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. (1978) (164)
Myocardial contraction bands revisited. (1986) (163)
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. (1996) (155)
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. (1983) (153)
Adriamycin cardiotoxicity: Endomyocardial biopsy evidence of enhancement by irradiation (1977) (152)
Cocaine and the heart. (1987) (150)
Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. (1973) (150)
Cardiac damage produced by direct current countershock applied to the heart. (1979) (146)
Percutaneous transvenous endomyocardial biopsy. (1973) (142)
Accuracy of biplane and multiplane transesophageal echocardiography in diagnosis of typical acute aortic dissection and intramural hematoma. (1996) (140)
Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. (1973) (139)
The pathology and etiology of cocaine-induced heart disease. (1988) (138)
PATHOGENESIS AND PREVENTION OF GRAFT ARTERIOSCLEROSIS IN AN EXPERIMENTAL HEART TRANSPLANT MODEL (1981) (138)
A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients. Etiology and prognosis of restrictive-constrictive physiology. (1989) (138)
Graft coronary disease: the lesions and the patients. (1989) (135)
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease (1991) (135)
Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. (2005) (133)
Incidence of myocarditis in peripartum cardiomyopathy. (1994) (133)
Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits. (1983) (131)
Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. (1978) (122)
Acute myocardial infarction in cardiac transplant recipients. (1989) (122)
INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI‐CD4 MONOCLONAL ANTIBODY THERAPY (1990) (116)
Transesophageal echocardiography and its potential for esophageal damage. (1990) (116)
The role of transbronchial biopsies in the management of lung transplant recipients. (1993) (116)
Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. (1991) (116)
Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. (1987) (108)
Anthracycline-associated cardiac and renal damage in rabbits. Evidence for mediation by vasoactive substances. (1981) (108)
Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. (1987) (106)
CYTOKINE GENE EXPRESSION IN REJECTING CARDIAC ALLOGRAFTS (1992) (105)
Cardiac abnormalities in myotonic dystrophy. Electrophysiologic and histopathologic studies. (1979) (102)
The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. (1998) (99)
Cardiac transplantation: the Stanford experience in the cyclosporine era. (1994) (99)
Mildly dilated congestive cardiomyopathy. (1985) (97)
Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. (1992) (96)
Intravascular Ultrasound Imaging of Coronary Arteries: Is Three Layers the Norm? (1992) (92)
Echocardiographic recognition and implications of ventricular hypertrophic trabeculations and aberrant bands. (1984) (89)
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. (1995) (89)
Efficacy and cost of cardiac monitoring in patients receiving doxorubicin (1982) (89)
Pathology and etiology of chronic rejection of the heart. (1994) (86)
Cardiac sarcoidosis: response to steroids and transplantation. (1987) (86)
Leukocytic Infiltrates in Idiopathic Dilated Cardiomyopathy: A Source of Confusion with Active Myocarditis (1986) (85)
Granzyme A and perforin as markers for rejection in cardiac transplantation (1991) (84)
The durability of porcine xenograft valves and conduits in children. (1982) (81)
Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. (1990) (79)
Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. (1991) (79)
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. (1993) (79)
Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection. (1981) (79)
Correlative study of regional left ventricular histology and contractile function. (1977) (74)
Calcification of Porcine Prosthetic Heart Valves: A Radiographic and Light Microscopic Study (1982) (73)
Acute myocarditis: a diagnostic dilemma. (1987) (70)
Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys. (1991) (70)
Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine. (1984) (70)
Percutaneous method of laser transmyocardial revascularization. (1997) (69)
Distant Heart Procurement for Human Transplantation: Ultrastructural Studies (1980) (69)
Cardiac biopsy evidence for a cardiomyopathy associated with symptomatic mitral valve prolapse. (1978) (68)
Pharmacodynamics of Mycophenolate Mofetil after Heart Transplantation: New Mechanisms of Action and Correlations with Histologic Severity of Graft Rejection (2002) (68)
"Quilty" revisited: a 10-year perspective. (1995) (67)
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. (1989) (66)
Cardiac amyloidosis. Diagnosis by transvenous endomyocardial biopsy. (1975) (64)
Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart Transplantation: More Than a Hemodynamic Marker (2006) (64)
Isolated pulmonary rejection after combined heart-lung transplantation. (1985) (63)
Ultrasonic tissue characterization: detection of acute myocardial ischemia in dogs. (1985) (63)
Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells. (1995) (63)
Infection of glutaraldehyde-preserved porcine valve heterografts. (1979) (61)
Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. (1989) (60)
Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis. (1990) (60)
Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. (1989) (59)
Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. (1993) (59)
Long-term results, hemodynamics, and complications after combined heart and lung transplantation. (1985) (58)
Successful retransplantation of the human heart. (1977) (57)
Diabetes and dyslipidemia. A new model for transplant coronary artery disease. (1998) (57)
Mediation of Subacute Anthracycline Cardiotoxicity in Rabbits by Cardiac Histamine Release (1983) (57)
The cytodiagnosis of malignant lymphomas and Hodgkin's disease in cerebrospinal, pleural and ascitic fluids. (1975) (56)
Time course and cellular characteristics of the iliac artery response to acute balloon injury. An angiographic, morphometric, and immunocytochemical analysis in the cholesterol-fed New Zealand white rabbit. (1992) (54)
Long-term results of combined heart-lung transplantation: the Stanford experience. (1994) (53)
Myocardial innervation in long-term heart transplant survivors: a quantitative ultrastructural survey. (1988) (53)
Cardiac graft vascular disease. Nonselective involvement of large and small vessels. (1993) (52)
The morphological progression of viral myocarditis. (1986) (52)
Pathologic features in long-term cardiac allografts. (1990) (51)
AIRWAY PATHOLOGY IN THE TRANSPLANTED RAT LUNG (1986) (51)
COMBINED HEART AND LUNG TRANSPLANTATION (1983) (50)
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease. (1997) (50)
Primary pulmonary hypertension and pregnancy. (1986) (49)
Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review. (1986) (48)
Increasing pericardial effusion in cardiac transplant recipients. (1989) (46)
Methysergide-induced heart disease: a case of multivalvular and myocardial fibrosis. (1977) (46)
Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. (1998) (45)
Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis. (1995) (45)
Whipple's disease presenting as aortic insufficiency. (1981) (45)
The Status of Cardiac Transplantation, 1975 (1975) (44)
Reliability and usefulness of immunofluorescence in heart transplantation. (1995) (44)
Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. (1990) (44)
The revised ISHLT heart biopsy grading scale. (2005) (44)
Transvenous biopsy from canine orthotopic heart allografts. (1973) (44)
Diagnosis and treatment of allograft rejection in heart-lung transplant recipients. (1983) (43)
Long-term outcome after heart transplantation for peripartum cardiomyopathy. (1994) (42)
The incidence and significance of contraction bands in endomyocardial biopsies from normal human hearts. (1978) (41)
Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols. (1990) (41)
PHARMACODYNAMICS OF MYCOPHENOLIC ACID IN HEART ALLOGRAFT RECIPIENTS: CORRELATION OF LYMPHOCYTE PROLIFERATION AND ACTIVATION WITH PHARMACOKINETICS AND GRAFT HISTOLOGY1 (2000) (41)
Clinical heart-lung transplantation. (1984) (41)
Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. (1998) (39)
Selective inhibition of muscle gene expression by oxidative stress in cardiac cells. (1998) (39)
Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes. (1993) (38)
Myocyte hypertrophy in the transplanted heart. A morphometric analysis. (1987) (36)
Cardiac Growth After Pediatric Heart Transplantation (1992) (35)
Allescheria boydii infection of the brain (1972) (34)
The postsurgical heart. The pathology of cardiac transplantation. (1988) (34)
Acute rejection: significance of elapsed time after transplantation. (1994) (34)
Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. (1988) (34)
Physiological Distribution of Digoxin in Human Heart (1974) (33)
Solid organ transplant rejection : mechanisms, pathology, and diagnosis (1996) (33)
Pediatric cardiac transplantation. The Stanford experience. (1994) (33)
Infantile histiocytoid cardiomyopathy--myocardial or conduction system hamartoma: what is the cell type involved? (1993) (33)
Internal cardiac defibrillation: histopathology and temporal stability of defibrillation energy requirements. (1987) (32)
Thromboembolic complications with the indwelling balloon-tipped pulmonary arterial catheter. (1974) (32)
Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy. (1986) (31)
Endomyocardial biopsy diagnosis of acute rejection in cardiac allografts. (1990) (31)
Ultrastructure of Hancock Porcine Valvular Heterografts: Pre- and Post-Implantation Changes (1978) (31)
Ultrastructural morphometric analysis of endomyocardial biopsies. Idiopathic dilated cardiomyopathy, anthracycline cardiotoxicity, and normal myocardium. (1988) (29)
Combined heart-lung transplantation for end-stage Eisenmenger's syndrome. (1986) (29)
Doppler echocardiographic indices of diastolic function as markers of acute cardiac rejection. (1987) (28)
The diagnosis of canine orthotopic cardiac allograft rejection by transvenous endomyocardial biopsy. (1973) (28)
The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients. (1987) (28)
Endomyocardial biopsy in the diagnosis of toxoplasmic myocarditis. (1986) (28)
Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma. (1987) (28)
Acute myocarditis: is sampling error a contraindication for diagnostic biopsies? (1989) (27)
Histopathologic and electrophysiologic correlations in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmia. (1989) (27)
Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients (2005) (27)
Myocardial lymphocytes. Fact, fancy, or myocarditis? (1987) (27)
Cytokine gene expression in human cardiac allograft recipients. (1994) (26)
Morphologic effects of defibrillation: a preliminary report. (1984) (26)
The diagnosis of acute cardiac rejection by endomyocardial biopsy. (1988) (26)
The pathologic changes in long-term heart and lung transplant survivors. (1992) (25)
Comparison of cardiac rejection in heart and heart-lung transplantation. (1987) (25)
Ultrastructural features of familial cardiomyopathy. (1988) (24)
The aortic valve after heart transplantation. (1995) (24)
In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies. (1990) (24)
Pharmacotoxic myocardial disease: An endomyocardial study (2005) (23)
The lymphocyte subpopulations in cyclosporine-treated human heart rejection. (1985) (22)
Ultrastructural and functional studies on prolonged myocardial preservation in an experimental heart transplant model. (1982) (22)
Rejection of combined heart-lung transplants in rats. Function and pathology. (1987) (21)
Cytology of the cerebrospinal fluid in patients with Hodgkin's disease or malignant lymphoma. (1975) (21)
Recurrence of amyloid in a cardiac allograft four months after transplantation. (1989) (21)
Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy. (1978) (21)
Endomyocardial Changes in Anthracycline-Treated Patients with and without Irradiation (1979) (20)
Collagen profile in the transplanted heart. (1990) (20)
Is acute cardiac rejection a model of myocarditis in humans (1987) (20)
Transplant Coronary Artery Disease: A Novel Model Independent of Cellular Alloimmune Response (2001) (19)
Lymphographic accuracy in Hodgkin's disease and malignant lymphoma with a note on the "reactive" lymph node as a cause of most false-positive lymphograms 1974. (1973) (19)
THE USE OF GRANZYME A AS A MARKER OF HEART TRANSPLANT REJECTION IN CYCLOSPORINE OR ANTI‐CD4 MONOCLONAL ANTIBODY‐TREATED RATS (1993) (18)
Histamine-mediated myocardial damage in rabbits. (1982) (18)
Transvenous endomyocardial biopsy--application of a method for diagnosing heart disease. (1975) (18)
The surgical pathology of hypertrophic cardiomyopathy. (1987) (18)
LONG‐TERM CARDIAC AND PULMONARY HISTOLOGY IN PRIMATES FOLLOWING COMBINED HEART AND LUNG TRANSPLANTATION (1985) (17)
Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G. (1988) (17)
Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection. (2004) (17)
Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury. (1993) (17)
AN ASSESSMENT OF NVA2-CYCLOSPOMNE IN PRIMATE CARDIAC TRANSPLANTATION (1987) (17)
Ventricular aberrant bands and hypertrophic trabeculations. A clinical pathological correlation. (1988) (16)
Comprehensive Assessment of the Safety, Durability, Clinical Performance, and Healing Characteristics of a Double Velour Knitted Dacron Arterial Prosthesis (1980) (16)
The cellular infiltrate in cardiac allograft rejection in mice. (1977) (16)
Myocardial perfusion through naturally occurring subendocardial channels. (1997) (15)
Obliterative bronchiolitis in the transplanted rat lung. (1987) (15)
Rapid histological changes in endomyocardial biopsy specimens after myocarditis. (1990) (15)
Cyclosporine induced myocardial fibrosis: a unique controlled case report. (1985) (15)
Endomyocardial Biopsy Diagnosis of Myocarditis and Changes Following Immunsuppressive Treatment (1984) (15)
Graft coronary disease in pediatric heart and combined heart-lung transplant recipients: a study of fifteen cases. (1993) (15)
The diagnostic criteria of myocarditis by endomyocardial biopsy (2005) (15)
Dose Response of Fish Oil Versus Safflower Oil on Graft Arteriosclerosis in Rabbit Heterotopic Cardiac Allografts (1991) (15)
Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity. (1987) (14)
Phase I results of pullback atherectomy for hemodialysis access. (1994) (14)
Lymphographic Accuracy in Hodgkin's Disease and Malignant Lymphoma with a Note on the “Reactive” Lymph Node as a Cause of Most False-Positive Lymphograms (1990) (14)
Graft vascular disease in the great vessels and vasa vasorum. (1993) (14)
Therapeutic monitoring of mycophenolic acid (MPA): Assays of immune function in peripheral blood predict efficacy for inhibition of histologic graft rejection (1999) (13)
The safety and utility of endomyocardial biopsy in infants, children and adolescents. (1990) (13)
Ultrasonic characterization of acute cardiac rejection from temporal evolution of echocardiograms. (1986) (13)
Technetium-99m pyrophosphate in diagnosis of acute cardiac rejection in the rat with effect of cyclosporine: concise communication. (1984) (13)
6-Hydroxydopamine mediated cardiotoxicity in rabbits. (1988) (13)
Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo. (1991) (13)
DETECTION OF EPSTEIN‐BARR VIRUS IN CARDIAC BIOPSIES OF HEART TRANSPLANT PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS (1995) (13)
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. (1992) (13)
Late airflow obstruction in heart-lung transplantation recipients. (1985) (12)
Bronchoscopy after cardiopulmonary transplantation. (1985) (12)
Echocardiographic recognition of paraseptal structures. (1985) (12)
Transplant coronary vascular disease: histomorphometric properties and clinical correlations. (1988) (12)
Features of mildly dilated congestive cardiomyopathy compared with idiopathic restrictive cardiomyopathy and typical dilated cardiomyopathy. (1988) (12)
Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats. (1988) (12)
Assessment of cardiac rejection and immunosuppression by magnetic resonance imaging and spectroscopy. (1995) (11)
Left atrial myxoma: diagnosis, treatment, and cytological observations. (1975) (11)
The pathology of transplanted hearts. (1990) (10)
Atlas of Biopsy Pathology for Heart and Lung Transplantation (2000) (10)
Effect of chronic potassium depletion on digitalis-induced inotropy and arrhythmias. (1981) (10)
Evaluation of mRNA levels by the polymerase chain reaction in small cardiac tissue samples. (1991) (10)
Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats. (1994) (9)
Diverticulum of the left ventricle in hypertrophic cardiomyopathy. (1978) (9)
Myocarditis and endomyocardial biopsy. (1989) (9)
Multidimensional assessment of graft vascular disease (GVD) in aortic grafts by serial intravascular ultrasound in rhesus monkeys. (2000) (9)
Pathology of the transplanted heart and lung. (1990) (9)
Effects of fish oil on graft arteriosclerosis and MHC class II antigen expression in rat heterotopic cardiac allografts. (1991) (9)
Calcification of aortic versus mitral porcine bioprosthetic heart valves: a radiographic study comparing amounts of calcific deposits in valves explanted from the same patient. (1984) (9)
New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics. (2001) (9)
Does intracoronary ultrasound conflict with pathology? Comments from a panel discussion. (1995) (9)
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts. (1991) (8)
Coronary artery and peripheral vascular disease in cocaine users. (1995) (8)
Protective effect of clentiazem against epinephrine-induced cardiac injury in rats. (1993) (8)
Can histopathology guide immunosuppression for cardiac allograft rejection in the light of new techniques? (1997) (8)
Session VI: Rejection/infection: the limits of heart transplantation success. (1991) (8)
Telemetry of electrophysiologic variables from conscious dogs: system design, validation, and serial studies. (1984) (8)
Captopril Improves Hypertension and Cardiomyopathy in Rats With Pheochromocytoma (1990) (8)
Doxorubicin Cardiotoxicity: Serial Endomyocardial Biopsies and Systolic Time Intervals (1978) (8)
Refining pathological classification of acute rejection in cardiac allograft recipients: a multicenter study using peripheral blood gene expression profiling (2004) (7)
Selective T-cell depletion with Ox-38 anti-CD4 monoclonal antibody prevents cardiac allograft rejection in rats. (1990) (7)
Heart and lung transplantation for pulmonary hypertension. (1984) (7)
Chapter 11 – Diseases of the transplanted heart (1983) (7)
Transvenous intracardiac biopsy using a new catheter forceps. (1975) (7)
COMBINED HEART‐LUNG TRANSPLANTATION IN THE RAT: COMPARISON OF THORACIC AND ABDOMINAL OPERATION TECHNIQUES (1987) (7)
Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy (2004) (7)
A new method for assessing right-sided heart pressures using encapsulated microbubbles--a preliminary report. (1985) (6)
A new large-animal model for research of graft vascular disease. (1998) (6)
The conduction system in transplanted hearts. (1992) (6)
Pathology of human cardiac transplantation. (1995) (6)
Proceedings: Transvenous cardiac biopsy--application of new method for diagnosing heart disease. (1974) (6)
Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats. (1995) (6)
Accelerated posttransplant coronary arteriosclerosis in combined heart-lung transplantation. (1991) (6)
Leflunomide abrogates accelerated heart allograft rejection in presensitized rats. (1997) (5)
Combined heart and lung transplantation. (1983) (5)
Assessment of cardiac allograft rejection with electrophysiology of the conduction system and histopathology of the ventricle. (1992) (5)
Transvenous biopsy of mediastinal lymphoma invading the superior vena cava. (1980) (5)
Lipofuscin and lipid oxidation in human coronary endothelium. (1998) (5)
Correlation between the rise in acute phase proteins and histological evidence of ulceration in the rat following indomethacin treatment [proceedings]. (1979) (4)
Distribution of digoxin in the human heart. (1975) (4)
Autopsy findings after coronary rotational atherectomy. (1990) (4)
Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance. (1992) (4)
Cardiac transplantation. (1988) (4)
Cardiovascular pathology at the crossroads: the dilemma of cardiac pathologists. (2011) (4)
Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model. (2001) (4)
Results of heart-lung preservation for transplantation. (1984) (4)
Intravascular Ultrasound Imaging of Coronary Arteries (2005) (4)
VX-497 inhibits IMPDH and is the first rationally synthesized immunosuppressant to prolong allograft survival (1999) (4)
Sustained myocardial hypertrophy seven years or more after heart transplantation: a morphometric study of endomyocardial specimens. (1992) (4)
170: Gene expression profiling distinguishes moderate to severe from mild acute cellular rejection in cardiac allograft recipients (2007) (3)
Intracoronary Arterial Occlusion: A Novel Technique Potentially Useful for Ablation of Cardiac Arrhythmias (1997) (3)
Heart-lung transplantation: Cardiac clinicopathological correlations. (1996) (3)
Assessment of new immunosuppressive drugs in a rat cardiac allograft heterotopic model. (1992) (3)
PHARMACODYNAMICS (PD) OF MYCOPHENOLATE MOFETIL (MMF) AFTER HEART TRANSPLANTION IDENTIFY NEW MECHANISM OF ACTION AND CORRELATE WITH SEVERITY OF REJECTION (1999) (3)
Alterations in collagen of porcine valve heterografts in place from 3 to 94 months: The cause of leaflet calcific deposits and of perforations and tears (1980) (3)
Histamine Mediates Myocardial Damage by an H1 Mechanism Independent of Coronary Blood Flow (1990) (3)
Histopathological Diagnosis of Acute Myocarditis and Dilated Cardiomyopathy (1990) (2)
Problems in assessing infarction size by epicardial mapping: preliminary studies with quinidine. (1976) (2)
GRAFT REJECTION IN MYCOPHENOLIC ACID (MPA) TREATED HEART TRANSPLANT RECIPIENTS IS PREDICTED BY CHANGES IN LYMPHOCYTE FUNCTION OVER TIME (PHARMACODYNAMICS) (1999) (2)
417: Probabilistic modeling of rejection in cardiac allograft patients as measured by biopsy and molecular diagnostics (2006) (2)
Autologous pericardium versus a xenograft substitute in myocardial wound healing. (1986) (2)
Quilty effect in heterotopic cardiac allografts in malononitrilamide-treated rats. (1999) (2)
The IMPDH inhibitor VX-497 is the first rationally synthesized immunosuppressant to prolong allograft survival (1999) (2)
Monitoring Of Pharmacodynamics (pd), But Not Pharmacokinetics (pk), Differentiates The Relative Immunosuppressive Potencies Of Leflunomide And Its Malononitrilamide (mna) Analogs (1998) (2)
The use of 111in-labeled lymphocyte imaging to evaluate graft rejection following cardiac transplantation in dogs (2004) (2)
Immunological detection of human cardiac rejection. (1974) (2)
Comparative effect of cyclosporin A and G on weight gain of primates during the pubertal growth period. (1987) (1)
Pathology of the Heart and Great Vessels (1989) (1)
Themorphological progression ofviral myocarditis (1986) (1)
A Case of Multivalvular and Myocardial Fibrosis (2005) (1)
Cardiovascular pathology at the crossroads: The dilemma of cardiac pathologists. (1992) (1)
Bovine pericardial valves. Nine-year clinical experience with the Novacor left ventricular assist system. (1991) (1)
Cardiac biopsy interpretation. (1986) (1)
Pretransplant T-cell subset modulation confers donor-specific unresponsiveness in rats (1989) (1)
The Pathology of Congestive Heart Failure (1994) (1)
Correlation of an abnormal rest 201Tl myocardial image: Pathological findings in cardiac transplant recipients (2004) (1)
Contraction bands in human hearts: Pathology or artifact? (1977) (1)
Rationale and Design of a Trial to Evaluate the Cardiotoxocity of Weekly Schedules of Adriamycin, with Endomyocardial Biopsy used as an End Point (1982) (1)
Adriamycin cardiotoxicity. (1984) (1)
THE USE OF INDIUM-111 LABELED LYMPHOCYTE IMAGING TO EVALUATE GRAFT REJECTION FOLLOWING CARDIAC TRANSPLANTATION IN DOGS (1981) (1)
Different rates of cardiac and pulmonary rejection in combined heart-lung grafts in rats. (1987) (0)
Epinephrine-induced chronic cardiac injury in rats: Protective action of TA-3090, a new calcium antagonist (1988) (0)
Preischemic conditions affecting ischemic tolerance of the human and rabbit myocardium; A nuclearmagnetic resonance study (31P NMR) (1984) (0)
Differential cardiac and pulmonary rejection in the rat: Evidence suggesting a tissue-specific phenomenon (1990) (0)
Impact of prophylactic OKT3 on mild acute rejection of the cardiac allograft (1990) (0)
753-2 Biplane and Multiplane Transesophageal Echocardiography in Suspected Acute Aortic Dissection (1995) (0)
Pathology-epitomes of progress: endomyocardial biopsy. (1980) (0)
Viral infections. (1989) (0)
TISSUE CHARACTERIZATION Ultrasonic tissue characterization: detection of acute myocardial ischemia in dogs (2005) (0)
Detection ofCoxsackievirus B3RNAin Myocardial Tissues bythePolymerase ChainReaction (1991) (0)
GRAFT VASCULAR DISEASE (GVD) IN NON HUMAN PRIMATES: QUANTITATION OF CHANGES IN ARTERIAL AUTO- AND ALLOGRAFTS BY INTRAVASCULAR ULTRASOUND (IVUS) (1998) (0)
Xenotransplant News (2004) (0)
Myocardial biopsy in heart and heart-lung transplantation. (1989) (0)
Direct and indirect morphological markers of cocaine toxicity in the human heart. (1991) (0)
More Than a Hemodynamic Marker Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart (2006) (0)
[Intrathoracic half-working heart and lung transplantation in the rat]. (1994) (0)
Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance (1992) (0)
196 RELEVANCE OF COMBINED PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) STUDIES TO OPTIMIZE ADMINISTRATION AND EFFICACY OF TWO LEFLUNOMIDE ANALOGUES, THE MALONONITRILAMIDES (MNAS) HMR1279 AND HMR1715. (1997) (0)
Effect of antioxidant vitamins on transplant atherosclerosis in the Zucker rat model: Evidence for oxidative stress in the pathophysiology? (1998) (0)
Increasing Pericardial Effusion (2005) (0)
Computer-assisted densitometric analysis for quantification of cell surface antigen expression in monkey cardiac allografts: correspondence to histopathologic grade of rejection. (1993) (0)
CARDIOMYOPATHY Mildly dilated congestive cardiomyopathy (2005) (0)
Distinctive peripheral blood gene expression profiles in patients forming nodular endocardial infiltrates (quilty lesions) following heart transplantation (2005) (0)
The Durability of Porcine Xenograft (2005) (0)
Ventricular Function in Long-term Cardiac Allograft Recipients (2005) (0)
EVALUATION OF 99mTc PYROPHOSPHATE TO DIAGNOSE ACUTE CARDIAC REJECTION IN THE RAT WITH STUDIES ON THE EFFECT OF CYCLOSPORINE (1984) (0)
Reliability and usefulness of immunofluorescence in cardiac transplantations (1994) (0)
Long-term Outcome After Heart Transplantation for Peripartum Cardiomyopathy (1995) (0)
Quantitative pharmacologic responsesofnormal andatherosclerotic isolated humanepicardial coronaryarteries (1984) (0)
THERAPY AND PREVENTION CARDIAC TRANSPIANTATION Long-term results, hemodynamics, and complications after combined heart and lung transplantation (2005) (0)
The pathology of cardiomyopathies, myocarditis, drug-induced heart disease, cardiac transplantation (1986) (0)
733-4 Induction of Inducible Nitric Oxide Synthase (iNOS) mRNA and Protein in the Human Cardiac Allograft is Associated with Increased Myocardial cGMP Levels and Echocardiographic LV Dysfunction (1995) (0)
Doppler and M-Mode Echocardiographic Assessment of Left Ventricular Function during Acute Cardiac Allograft Rejection (1987) (0)

This paper list is powered by the following services:

Other Resources About Margaret Billingham

en.wikipedia.org

What Schools Are Affiliated With Margaret Billingham?

Margaret Billingham is affiliated with the following schools:

Image Attributions

Image Source for Margaret Billingham